期刊文献+

Correlation of serum MCP-1 and VE-cadherin levels with neural function and carotid atherosclerosis in patients with acute cerebral infarction

下载PDF
导出
摘要 Objective:To study the correlation of serum monocyte chemoattractant protein-1 (MCP-1) and vascular endothelial cadherin (VE-cadherin) levels with neural function and carotid atherosclerosis in patients with acute cerebral infarction.Methods:A total of 78 patients who were diagnosed with acute cerebral infarction in our hospital between May 2013 and August 2016 were selected as pathological group, and 80 healthy volunteers who received physical examination in our hospital during the same period were selected as control group. Serum was collected to determine the levels of MCP-1, VE-cadherin, nerve injury molecules, inflammatory mediators, proteases and their hydrolysate.Results:Serum MCP-1, VE-cadherin, NGB, NSE, S100β, HMGB-1, sCD40L, YKL-40, visfatin, CatK, MMP9 and ICTP levels of pathological group were significantly higher than those of control group;serum MCP-1 and VE-cadherin levels of pathological group were positively correlated with NGB, NSE, S100β, HMGB-1, sCD40L, YKL-40, visfatin, CatK, MMP9 and ICTP levels.Conclusion:Serum MCP-1 and VE-cadherin levels abnormally increase in patients with acute cerebral infarction, and are closely related to the nerve injury and atherosclerosis process.
作者 Yan-Bing Xi
出处 《Journal of Hainan Medical University》 2017年第9期129-133,共5页 海南医学院学报(英文版)
  • 相关文献

参考文献3

二级参考文献45

  • 1Isaacs A, Willems SM, Bos D, et al. Risk scores of common genetic variants for lipid levels influence atherosclerosis and incident coronary heart disease[J]. Arterioscler Thromb Vasc Biol, 2013, 33 (9): 2233-9.
  • 2Kato S, Endo I, Fujimura M, et al. Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: A pilot study [J]. Atherosclerosis, 2013,229(1): 182-5.
  • 3Mittal B, Mishra A, Srivastava A, et al. Matrix metalloproteinases in coronary artery disease[J]. Adv Clin Chem, 2014, 64: 1-72.
  • 4Manduteanu I, Simionescu M. Inflammation in atherosclerosis: a cause or a result of vascular disorders?[J]. J Cell Mol Med, 2012, 16 (9): 1978-90.
  • 5Pant S, Deshmukh A, Guntmurthy GS, et al. Inflammation and atherosclerosis-revisited[J]. J Cardiovasc Pharmacol Ther, 2014, 19 (2): 170-8.
  • 6Messerli FH, Mancia G, Coati CR, et al. Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology[J]. Eur Heart J, 2006, 27(23): 2902-3.
  • 7Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/ Non-ST-Elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association Tas[J]. Circulation, 2011, 123(18): e426-579.
  • 8Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur Heart J, 2012, 33(20): 2569-619.
  • 9Cheng XW, Kikuchi R, Ishii H, et al. Circulating cathepsin K as a potential novel biomarker of coronary artery disease [J].Atherosclerosis, 2013, 228(1): 211-6.
  • 10Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome [J]. Cardiovasc Res, 2003, 59(4): 812-23.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部